The effects of androstanediol and estradiol on prostatic growth were investigated in castrate dogs. Estrogens along resulted in no significant change in prostatic weight, whereas androstanediol produced growth comparable to that in uncastrated controls. Androstanediol plus estradiol resulted in an even more striking increase in prostate growth. Approximately half the animals receiving androstanediol alone and all of those receiving androstanediol plus estradiol fulfill the weight and histological criteria for prostatic hypertrophy in the dog. Since both these steroid hormones are presumed to be normal secretory products of the testis, it is possible that they are involved in the pathogenesis of prostatic hypertrophy in the dog.
P C Walsh, J D Wilson
Year: | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 | 2005 | 2004 | 2003 | 2002 | 2001 | 2000 | 1999 | 1998 | 1997 | 1996 | 1995 | 1994 | 1993 | 1992 | 1991 | 1990 | 1989 | 1988 | 1987 | 1986 | 1985 | 1984 | 1983 | 1982 | 1981 | 1980 | 1979 | 1978 | 1977 | 1974 | 1970 | Total |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Citations: | 1 | 1 | 3 | 2 | 2 | 2 | 8 | 4 | 3 | 2 | 2 | 7 | 5 | 5 | 5 | 1 | 3 | 5 | 4 | 10 | 5 | 6 | 8 | 6 | 10 | 5 | 7 | 16 | 10 | 10 | 7 | 15 | 7 | 8 | 11 | 12 | 6 | 10 | 14 | 6 | 12 | 9 | 16 | 14 | 7 | 6 | 1 | 1 | 320 |
Title and authors | Publication | Year |
---|---|---|
Animal Models and Human Reproduction
SJ Wright |
Animal Models and Human Reproduction | 2017 |
Estradiol promotes epithelial-to-mesenchymal transition in human benign prostatic epithelial cells
X Shi, Y Peng, X Du, H Liu, H Klocker, Q Lin, J Shi, J Zhang |
The Prostate | 2017 |
Magnetic Resonance Imaging and Molecular Characterization of a Hormone-Mediated Murine Model of Prostate Enlargement and Bladder Outlet Obstruction
EM McAuley, D Mustafi, BW Simons, R Valek, M Zamora, E Markiewicz, S Lamperis, A Williams, BB Roman, C Vezina, G Karczmar, A Oto, DJ Griend |
The American Journal of Pathology | 2017 |
Transition from androgenic to neurosteroidal action of 5α-androstane-3α, 17β-diol through the type A γ-aminobutyric acid receptor in prostate cancer progression
D Xia, DV Lai, W Wu, ZD Webb, Q Yang, L Zhao, Z Yu, JE Thorpe, BC Disch, MA Ihnat, M Jayaraman, DN Dhanasekaran, KL Stratton, MS Cookson, KM Fung, HK Lin |
The Journal of Steroid Biochemistry and Molecular Biology | 2017 |
Metabolic syndrome and benign prostatic hyperplasia: An update
HY Ngai, KK Yuen, CM Ng, CH Cheng, SK Chu |
Asian Journal of Urology | 2017 |
Benign prostatic hyperplasia after prostatic arterial embolization in a canine model: A 3T multiparametric MRI and whole-mount step-section pathology correlated longitudinal study: Embolization for BPH
B Li, A Xu, N Wang, X Min, Z Feng, M Deng, L Li, J Cai, Z Kang, K Jiang, D Kuang, L Wang |
Journal of magnetic resonance imaging : JMRI | 2017 |
The association between the serum concentration of canine prostate specific esterase (CPSE) and the size of the canine prostate
BS Holst, E Holmroos, L Friling, S Hanås, LM Langborg, MA Franko, K Hansson |
Theriogenology | 2017 |
Canine prostate models in preclinical studies of minimally invasive interventions: part II, benign prostatic hyperplasia models
F Sun, C Báez-Díaz, FM Sánchez-Margallo |
Translational andrology and urology | 2017 |